2 completed, 1 not yet recruiting. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Not yet recruiting 1 |
| Phase 1 | 1 | Not yet recruiting 1 |
Follow Shingrix®: new trials by email Literature Review of Shingrix® trials Research Report on Shingrix®
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Recombinant Herpes Zoster Vaccine Recombinant Herpes Zoster Vaccine (SCTV04C) Low-Dose, Recombinant Herpes Zoster Vaccine (SCTV04C) High-Dose, Placebo control: Saline - Herpes Zoster | Phase 1 / Phase 2 | Not yet recruiting | Sinocelltech Ltd. | 540 | 2025-02-15 | 2025-01-30 |
| Immunogenicity and Safety of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 30 Years and Above Low dose Recombinant Herpes Zoster Vaccine (CHO cells), High dose Recombinant Herpes Zoster Vaccine (CHO cells), Positive control - Herpes Zoster | Phase 2 | Completed | MAXVAX Biotechnology Limited Liability Company | 924 | 2023-05-07 | 2026-10-15 |
| Systems Biology of Zoster Vaccine Shingrix® - Zoster, Zoster Varicella | Phase 2 | Completed | Emory University | 38 | 2019-11-14 | 2024-07-30 |
Herpes Zoster (3) · Chickenpox (1)
Emory University (1) · MAXVAX Biotechnology Limited Liability Company (1) · Sinocelltech Ltd. (1)
China (2) · United States (1)
Nadine Rouphael, MD (1) · Yanxia Wang (1)
U19AI090023 (1)